{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T17:35:01Z","timestamp":1773768901667,"version":"3.50.1"},"reference-count":215,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2005,8,1]],"date-time":"2005-08-01T00:00:00Z","timestamp":1122854400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacology & Therapeutics"],"published-print":{"date-parts":[[2005,8]]},"DOI":"10.1016\/j.pharmthera.2005.03.001","type":"journal-article","created":{"date-parts":[[2005,5,18]],"date-time":"2005-05-18T11:58:54Z","timestamp":1116417534000},"page":"177-197","source":"Crossref","is-referenced-by-count":34,"title":["Pathophysiological basis for the prophylaxis of preeclampsia through early supplementation with antioxidant vitamins"],"prefix":"10.1016","volume":"107","author":[{"given":"Ram\u00f3n","family":"Rodrigo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mauro","family":"Parra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cleofina","family":"Bosco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Virginia","family":"Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pilar","family":"Barja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9","family":"Guajardo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rodrigo","family":"Messina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pharmthera.2005.03.001_bib1","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1080\/07315724.1990.10720386","article-title":"Maternal and fetal plasma vitamin E to total lipid ratio and fetal RBC antioxidant function during gestational development","volume":"9","author":"Abbasi","year":"1990","journal-title":"J Am Coll Nutr"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib2","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/S0014-5793(00)02305-X","article-title":"NADPH oxidase activity is required for endothelial cell proliferation and migration","volume":"486","author":"Abid","year":"2000","journal-title":"FEBS Lett"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib3","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.2174\/1381612033454487","article-title":"Pharmacological treatment of hypertension in pregnancy","volume":"9","author":"Afifi","year":"2003","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib4","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s004040050271","article-title":"Maternal levels of vitamin E in normal and preeclamptic pregnancy","volume":"263","author":"Akyol","year":"2000","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib5","doi-asserted-by":"crossref","first-page":"284","DOI":"10.2310\/6650.2003.3593","article-title":"Antioxidant potential and transferrin, ceruloplasmin, and lipid peroxidation levels in women with preeclampsia","volume":"51","author":"Aksoy","year":"2003","journal-title":"J Invest Med"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib6","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1161\/01.RES.0000147365.86159.f5","article-title":"Elevated placental soluble vascular endothelial growth factor receptor-1 inhibits angiogenesis in preeclampsia","volume":"95","author":"Ahmad","year":"2004","journal-title":"Circ Res"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib7","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1097\/00001703-199612000-00009","article-title":"Pregnancy hypertension and uterine artery Doppler ultrasound","volume":"8","author":"Aquilina","year":"1996","journal-title":"Curr Opin Obstet Gynecol"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib8","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0301-2115(03)00368-3","article-title":"Plasma malondialdehyde, superoxide dismutase, sE-selectin, fibronectin, endothelin-1 and nitric oxide levels in women with preeclampsia","volume":"113","author":"Aydin","year":"2004","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib9","doi-asserted-by":"crossref","first-page":"7893","DOI":"10.1158\/0008-5472.CAN-04-1119","article-title":"BRCA1 induces antioxidant gene expression and resistance to oxidative stress","volume":"64","author":"Bae","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib10","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1146\/annurev.iy.12.040194.001041","article-title":"Function and activation of NF-kappa B in the immune system","volume":"12","author":"Baeuerle","year":"1994","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib11","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1093\/ajcn\/28.1.59","article-title":"Vitamin profile of 174 mothers and newborns at parturition","volume":"28","author":"Baker","year":"1975","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib12","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/00005344-200103000-00012","article-title":"Effect of vitamin C on the availability of tetrahydrobiopterin in human endothelial cells","volume":"37","author":"Baker","year":"2001","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib13","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1146\/annurev.immunol.14.1.649","article-title":"The NF-kappa B and I kappa B proteins: new discoveries and insights","volume":"14","author":"Baldwin","year":"1996","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib14","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1042\/cs0910711","article-title":"Plasma and urinary 8-iso-prostane as an indicator of lipid peroxidation in pre-eclampsia and normal pregnancy","volume":"91","author":"Barden","year":"1996","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib15","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1161\/hy1101.092969","article-title":"Study of plasma factors associated with neutrophil activation and lipid peroxidation in preeclampsia","volume":"38","author":"Barden","year":"2001","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib16","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1515\/JPM.2003.072","article-title":"Maternal erythrocyte malondialdehyde level in preeclampsia prediction: a longitudinal study","volume":"31","author":"Basbug","year":"2003","journal-title":"J Perinat Med"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib17","first-page":"142","article-title":"Significance of changes in lipid peroxides and antioxidant enzyme activities in pregnant women with preeclampsia and eclampsia","volume":"27","author":"Bayhan","year":"2000","journal-title":"Clin Exp Obstet Gynecol"},{"issue":"5 Pt 1","key":"10.1016\/j.pharmthera.2005.03.001_bib18","doi-asserted-by":"crossref","first-page":"C1424","DOI":"10.1152\/ajpcell.1996.271.5.C1424","article-title":"Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly","volume":"271","author":"Beckman","year":"1996","journal-title":"Am J Physiol"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib19","first-page":"131","article-title":"The role of nitric oxide metabolites during pregnancy","volume":"42","author":"Begum","year":"1996","journal-title":"Kobe J Med Sci"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib20","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1159\/000064693","article-title":"Plasma levels of vitamin E in pregnant women prior to the development of preeclampsia and other hypertensive complications","volume":"54","author":"Ben-Haroush","year":"2002","journal-title":"Gynecol Obstet Invest"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib21","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0014-2999(98)00791-2","article-title":"Peroxynitrite-mediated attenuation of alpha- and beta-adrenoreceptor against-induced vascular responses in vivo","volume":"364","author":"Benkuski","year":"1999","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib22","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/S1701-2163(16)31003-9","article-title":"Current concepts in the use of antioxidants for the treatment of preeclampsia","volume":"25","author":"Bilodeau","year":"2003","journal-title":"J Obstet Gynaecol Can"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib23","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.ajog.2003.12.033","article-title":"N-acetylcysteine restores nitric oxide-mediated effects in the fetoplacental circulation of preeclamptic patients","volume":"191","author":"Bisseling","year":"2004","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib24","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1016\/S0531-5565(01)00133-4","article-title":"Lipid hydroperoxide-mediated DNA damage","volume":"36","author":"Blair","year":"2001","journal-title":"Exp Gerontol"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib25","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1161\/01.CIR.98.18.1842","article-title":"Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia","volume":"98","author":"Boger","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib26","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1093\/ajcn\/76.4.703","article-title":"The European perspective on vitamin E: current knowledge and future research","volume":"76","author":"Brigelius-Flohe","year":"2002","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib27","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.jsgi.2004.03.003","article-title":"Placental oxidative stress: from miscarriage to preeclampsia","volume":"11","author":"Burton","year":"2004","journal-title":"J Soc Gynecol Investig"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib28","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/S0002-9378(99)70518-1","article-title":"Maternal arterial connections to the placental intervillous space during the first trimester of human pregnancy: the Boyd collection revisited","volume":"181","author":"Burton","year":"1999","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib29","doi-asserted-by":"crossref","first-page":"32801","DOI":"10.1074\/jbc.273.49.32801","article-title":"Alpha-tocopherol inhibits the respiratory burst in human monocytes. Attenuation of p47 (phox) membrane translocation and phosphorylation","volume":"273","author":"Cachia","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib30","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/S0306-5456(01)00247-9","article-title":"Dyslipidemia in early second trimester is mainly a feature of women with early onset pre-eclampsia","volume":"108","author":"Clausen","year":"2001","journal-title":"Br J Obstet Gynecol"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib31","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/S0306-9877(03)00044-6","article-title":"Cellular bases for the lipid-related aspects of preeclampsia","volume":"60","author":"Coffey","year":"2003","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib32","doi-asserted-by":"crossref","first-page":"C395","DOI":"10.1152\/ajpcell.00295.2001","article-title":"Peroxynitrite increases iNOS through NF-\u03baB and decreases prostacyclin synthase in endothelial cells","volume":"282","author":"Cooke","year":"2002","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib33","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1161\/hh1401.093459","article-title":"Investigation of relationship between reduced, oxidized, and protein-bound homocysteine and vascular endothelial function in healthy human subjects","volume":"89","author":"Chambers","year":"2001","journal-title":"Circ Res"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib34","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1139\/y93-109","article-title":"Partners in defense, vitamin E and vitamin C","volume":"71","author":"Chan","year":"1993","journal-title":"Can J Physiol Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib35","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/S0140-6736(99)80010-5","article-title":"Effect of antioxidants on the occurrence of pre-eclampsia in women at increased risk: a randomised trial","volume":"354","author":"Chappell","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib36","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1067\/mob.2002.122969","article-title":"A longitudinal study of biochemical variables in women at risk of preeclampsia","volume":"187","author":"Chappell","year":"2002","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib37","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1067\/mob.2002.125735","article-title":"Vitamin C and E supplementation in women at risk of preeclampsia is associated with changes in indices of oxidative stress and placental function","volume":"187","author":"Chappell","year":"2002","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib38","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/S0278-6915(99)00090-3","article-title":"Intracellular antioxidants: from chemical to biochemical mechanisms","volume":"37","author":"Chaudiere","year":"1999","journal-title":"Food Chem Toxicol"},{"issue":"3 Pt 2","key":"10.1016\/j.pharmthera.2005.03.001_bib39","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1161\/hy09t1.094005","article-title":"Antioxidant effects of vitamins C and E are associated with altered activation of vascular NADPH oxidase and superoxide dismutase in stroke-prone SHR","volume":"38","author":"Chen","year":"2001","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib40","first-page":"257","article-title":"Nitric oxide production increases during normal pregnancy and decreases in preeclampsia","volume":"32","author":"Choi","year":"2002","journal-title":"Ann Clin Lab Sci"},{"issue":"1 Pt 2","key":"10.1016\/j.pharmthera.2005.03.001_bib41","first-page":"F48","article-title":"Plasma and 24-h NO(x) and cGMP during normal pregnancy and preeclampsia in women on a reduced NO(x) diet","volume":"277","author":"Conrad","year":"1999","journal-title":"Am J Physiol"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib42","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1159\/000051036","article-title":"Vascular biology of the isoprostanes","volume":"38","author":"Cracowski","year":"2001","journal-title":"J Vasc Res"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib43","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.ajog.2003.08.042","article-title":"l-Arginine erythrocyte transport in normal pregnant and preeclamptic women","volume":"190","author":"da Costa","year":"2004","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib44","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.ijcard.2003.07.012","article-title":"17Beta-estradiol preserves endothelial function by reduction of the endogenous nitric oxide synthase inhibitor level","volume":"96","author":"Dai","year":"2004","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib45","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.0001-6349.2004.00291.x","article-title":"Plasma homocysteine in early and late pregnancies complicated with preeclampsia and isolated intrauterine growth restriction","volume":"83","author":"D'Anna","year":"2004","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib46","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/S0002-9378(96)70341-1","article-title":"Urine but not plasma nitric oxide metabolites are decreased in women with preeclampsia","volume":"174","author":"Davidge","year":"1996","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib47","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1097\/01.ASN.0000135975.90889.60","article-title":"New aspects in the pathophysiology of preeclampsia","volume":"15","author":"Davison","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib48","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1161\/01.CIR.0000058200.90059.B1","article-title":"AT1 receptor agonistic antibodies from preeclamptic patients stimulate NADPH oxidase","volume":"107","author":"Dechend","year":"2003","journal-title":"Circulation"},{"issue":"7 Pt 1","key":"10.1016\/j.pharmthera.2005.03.001_bib49","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/S0895-7061(02)02278-1","article-title":"Angiotensin converting enzyme inhibition and angiotensin II AT1-receptor blockade reduce the levels of asymmetrical N(G), N(G)-dimethylarginine in human essential hypertension","volume":"15","author":"Delles","year":"2002","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib50","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s00404-002-0465-6","article-title":"Nitric oxide production is not altered in preeclampsia","volume":"269","author":"Diejomaoh","year":"2004","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib51","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/S0003-9861(02)00064-4","article-title":"Noninvasive diagnostic tool for inflammation-induced oxidative stress using electron spin resonance spectroscopy and an extracellular cyclic hydroxylamine","volume":"402","author":"Dikalov","year":"2002","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib52","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1095\/biolreprod.103.015800","article-title":"Homocysteine induces trophoblast cell death with apoptotic features","volume":"69","author":"Di Simone","year":"2003","journal-title":"Biol Reprod"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib53","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1053\/plac.2002.0851","article-title":"Modulation of prostacyclin and thromboxane secretion by cytotrophoblasts from normal and pre-eclamptic human pregnancies","volume":"23","author":"Ding","year":"2002","journal-title":"Placenta"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib54","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0301-2115(00)00532-7","article-title":"Increase of endothelial nitric oxide synthase and endothelin-1 mRNA expression in human placenta during gestation","volume":"97","author":"Dotsch","year":"2001","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib55","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0009-9120(01)00230-2","article-title":"New scope in angiogenesis: role of vascular endothelial growth factors (VEGF), NO, lipid peroxidation, and vitamin E in the pathophysiology of pre-eclampsia among Egyptian females","volume":"34","author":"El-Salahy","year":"2001","journal-title":"Clin Biochem"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib56","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1097\/01.ASN.0000132474.50966.DA","article-title":"Endothelial dysfunction","volume":"15","author":"Endemann","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib57","doi-asserted-by":"crossref","first-page":"549","DOI":"10.3109\/00365519409088567","article-title":"Effects of free fatty acids found increased in women who develop pre-eclampsia on the ability of endothelial cells to produce prostacyclin, cGMP and inhibit platelet aggregation","volume":"54","author":"Endresen","year":"1994","journal-title":"Scand J Clin Lab Invest"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib58","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.amjhyper.2004.03.666","article-title":"Maternal plasma lipid concentrations in early pregnancy and risk of preeclampsia","volume":"17","author":"Enquobahrie","year":"2004","journal-title":"Am J Hypertens"},{"issue":"6 Pt 1","key":"10.1016\/j.pharmthera.2005.03.001_bib59","doi-asserted-by":"crossref","first-page":"C1619","DOI":"10.1152\/ajpcell.1993.264.6.C1619","article-title":"Evidence for the existence of F2-isoprostane receptors on rat vascular smooth muscle cells","volume":"264","author":"Fukunaga","year":"1993","journal-title":"Am J Physiol"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib60","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1097\/00005344-199526003-00016","article-title":"Stimulatory effect of 8-epi-PGF2alpha, an F2-isoprostane, on endothelin-1 release","volume":"26","author":"Fukunaga","year":"1995","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib61","doi-asserted-by":"crossref","first-page":"23659","DOI":"10.1074\/jbc.272.38.23659","article-title":"Differential transcriptional regulation of the two vascular endothelial growth factor receptor genes. Flt-1, but not Flk-1\/KDR, is up-regulated by hypoxia","volume":"272","author":"Gerber","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib62","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0301-2115(00)00427-9","article-title":"Lipid-mediated endothelial dysfunction: a common factor to preeclampsia and chronic vascular disease","volume":"92","author":"Gratacos","year":"2000","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib63","doi-asserted-by":"crossref","first-page":"896","DOI":"10.3109\/00016349609055024","article-title":"Variation in lipid levels during pregnancy in women with different types of hypertension","volume":"75","author":"Gratacos","year":"1996","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib64","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/S1470-0328(03)02949-5","article-title":"Increased susceptibility to low density lipoprotein oxidation in women with a history of pre-eclampsia","volume":"110","author":"Gratacos","year":"2003","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib65","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S1521-6934(03)00009-9","article-title":"Homocysteine and pregnancy","volume":"17","author":"Hague","year":"2003","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"2 Pt 1","key":"10.1016\/j.pharmthera.2005.03.001_bib66","first-page":"L163","article-title":"Regulation of endothelial cell xanthine dehydrogenase xanthine oxidase gene expression by oxygen tension","volume":"266","author":"Hassoun","year":"1994","journal-title":"Am J Physiol"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib67","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/S0002-9378(98)70437-5","article-title":"Plasma concentrations of asymmetric dimethylarginine, a natural inhibitor of nitric oxide synthase, in normal pregnancy and preeclampsia","volume":"178","author":"Holden","year":"1998","journal-title":"Am J Obstet Gynecol"},{"issue":"5 Pt 1","key":"10.1016\/j.pharmthera.2005.03.001_bib68","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1097\/01.AOG.0000124806.39111.ba","article-title":"Leukocyte adhesion molecules and reactive oxygen species in preeclampsia","volume":"103","author":"Holthe","year":"2004","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib69","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.1749-6632.1972.tb27878.x","article-title":"Relationship between tocopherol and serum lipid levels for determination of nutritional adequacy","volume":"203","author":"Horwitt","year":"1972","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib70","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1046\/j.1525-1373.1999.d01-139.x","article-title":"Oxidative stress in the pathogenesis of preeclampsia","volume":"222","author":"Hubel","year":"1999","journal-title":"Proc Soc Exp Biol Med"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib71","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/S0002-9378(96)70336-8","article-title":"Fasting serum triglycerides, free fatty acids, and malondialdehyde are increased in preeclampsia, are positively correlated, and decrease within 48 hours post partum","volume":"174","author":"Hubel","year":"1996","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib72","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S0891-5849(97)00010-5","article-title":"Increased ascorbate radical formation and ascorbate","volume":"23","author":"Hubel","year":"1997","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib73","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/S0026-0495(98)90337-7","article-title":"Small low-density lipoproteins and vascular cell adhesion molecule-1 are increased in association with hyperlipidemia in preeclampsia","volume":"47","author":"Hubel","year":"1998","journal-title":"Metabolism"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib74","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3109\/10715769309145868","article-title":"The reaction of NO with superoxide","volume":"18","author":"Huie","year":"1993","journal-title":"Free Radic Res Commun"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib75","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/S0002-9440(10)61778-6","article-title":"In vitro ischemia\u2013reperfusion injury in term human placenta as a model for oxidative stress in pathological pregnancies","volume":"159","author":"Hung","year":"2001","journal-title":"Am J Pathol"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib76","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1161\/01.RES.0000024411.22110.AA","article-title":"Hypoxia-reoxygenation: a potent inducer of apoptotic changes in the human placenta and possible etiological factor in preeclampsia","volume":"90","author":"Hung","year":"2002","journal-title":"Circ Res"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib77","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/0003-9861(92)90431-U","article-title":"Peroxynitrite-mediated tyrosine nitration catalyzed by superoxide dismutase","volume":"298","author":"Ischiropoulos","year":"1992","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib78","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1016\/S0002-9440(10)64849-3","article-title":"Onset of maternal arterial blood flow and placental oxidative stress. A possible factor in human early pregnancy failure","volume":"157","author":"Jauniaux","year":"2000","journal-title":"Am J Pathol"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib79","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1210\/jc.2003-031332","article-title":"Distribution and transfer pathways of antioxidant molecules inside the first trimester human gestational sac","volume":"89","author":"Jauniaux","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib80","doi-asserted-by":"crossref","first-page":"4835","DOI":"10.1210\/en.2004-1028","article-title":"Hypoxia and sFlt-1 in preeclampsia: the \u201cchicken-and-egg\u201d question","volume":"145","author":"Karumanchi","year":"2004","journal-title":"Endocrinology"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib81","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/S0029-7844(02)02169-5","article-title":"Increased endothelial monocyte chemoattractant protein-1 and interleukin-8 in preeclampsia","volume":"100","author":"Kauma","year":"2002","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib82","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0301-2115(00)00243-8","article-title":"Vitamin E and C in preeclampsia","volume":"93","author":"Kharb","year":"2000","journal-title":"Eur J Obstet Reprod Biol"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib83","first-page":"1658","article-title":"Generation of the 8-epi-prostaglandin F2alpha in vitro and in vivo via the cyclooxygenases","volume":"282","author":"Klein","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib84","doi-asserted-by":"crossref","first-page":"4651","DOI":"10.1073\/pnas.88.11.4651","article-title":"Nitric oxide: an endogenous modulator of leukocyte adhesion","volume":"88","author":"Kubes","year":"1991","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib85","first-page":"901","article-title":"Lipid peroxides, anti-oxidants and nitric oxide in patients with pre-eclampsia and essential hypertension","volume":"6","author":"Kumar","year":"2000","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib86","doi-asserted-by":"crossref","first-page":"139","DOI":"10.5483\/BMBRep.2004.37.2.139","article-title":"An important role of Nrf2\u2013ARE pathway in the cellular defense mechanism","volume":"37","author":"Lee","year":"2004","journal-title":"J Biochem Mol Biol"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib87","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1097\/00004872-200302000-00032","article-title":"Neutrophil activation and production of reactive oxygen species in preeclampsia","volume":"21","author":"Lee","year":"2003","journal-title":"J Hypertens"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib88","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1161\/01.HYP.0000062021.68464.9D","article-title":"NADPH oxidase activity in preeclampsia with immortalized lymphoblasts used as models","volume":"41","author":"Lee","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib89","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1038\/sj.ejcn.1601976","article-title":"Influence of maternal serum levels of vitamins C and E during the second trimester on birth weight and length","volume":"58","author":"Lee","year":"2004","journal-title":"Eur J Clin Nutr"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib90","first-page":"293","article-title":"A short-term supplementation of pregnant women before delivery does not improve significantly the vitamin E status of neonates-low efficiency of the vitamin E placental transfer","volume":"68","author":"Leger","year":"1998","journal-title":"Int J Vitam Nutr Res"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib91","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1056\/NEJMoa031884","article-title":"Circulating angiogenic factors and the risk of preeclampsia","volume":"350","author":"Levine","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib92","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/S0891-5849(97)00060-9","article-title":"How does superoxide dismutase protect against tumor necrosis factor: a hypothesis informed by effect of superoxide on \u201cfree\u201d iron","volume":"23","author":"Liochev","year":"1997","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib93","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1006\/abio.1996.9990","article-title":"Assay of aldehydes from lipid peroxidation: gas chromatography-mass spectrometry compared to thiobarbituric acid","volume":"245","author":"Liu","year":"1997","journal-title":"Anal Biochem"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib94","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/BF02255929","article-title":"The isoprostanes: unique bioactive products of lipid peroxidation. An overview","volume":"5","author":"Liu","year":"1998","journal-title":"J Biomed Sci"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib95","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.freeradbiomed.2004.04.035","article-title":"A comprehensive study of oxidative stress and antioxidant status in preeclampsia and normal pregnancy","volume":"37","author":"Llurba","year":"2004","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib96","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1055\/s-2007-1016250","article-title":"Plasma lipids and vascular dysfunction in preeclampsia","volume":"16","author":"Lorentzen","year":"1998","journal-title":"Semin Reprod Endocrinol"},{"issue":"11 Suppl 2","key":"10.1016\/j.pharmthera.2005.03.001_bib97","first-page":"II3","article-title":"Biology of the endothelium","volume":"20","author":"Luscher","year":"1997","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib98","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1172\/JCI18015","article-title":"Soluble VEGF receptor Flt1: the elusive preeclampsia factor discovered?","volume":"111","author":"Luttun","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib99","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1001\/jama.291.7.823","article-title":"Plasma concentrations of asymmetric dimethylarginine (ADMA) in Colombian women with pre-eclampsia","volume":"291","author":"Maas","year":"2004","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib100","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0301-2115(99)00023-8","article-title":"Lipid peroxidation and antioxidant in preeclampsia","volume":"85","author":"Madazli","year":"1999","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib101","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1080\/0144361021000003573","article-title":"The plasma and placental levels of malondialdehyde, glutathione and superoxide dismutase in pre-eclampsia","volume":"22","author":"Madazli","year":"2002","journal-title":"J Obstet Gynaecol"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib102","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1053\/plac.2000.0589","article-title":"Human placental NAD(P)H oxidase: solubilization and properties","volume":"22","author":"Manes","year":"2001","journal-title":"Placenta"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib103","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0002-9440(10)64733-5","article-title":"Invasive cytotrophoblasts manifest evidence of oxidative stress in preeclampsia","volume":"156","author":"Many","year":"2000","journal-title":"Am J Pathol"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib104","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jsgi.2003.08.003","article-title":"Impairment of fetal endothelium-dependent relaxation in a rat model of preeclampsia by chronic nitric oxide synthase inhibition","volume":"11","author":"Martinez-Orgado","year":"2004","journal-title":"J Soc Gynecol Investig"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s004180100301","article-title":"Enzyme histochemically detectable NAD(P)H oxidase in human placental trophoblast: normal, preeclamptic, and fetal growth restriction-complicated pregnancy","volume":"116","author":"Matsubara","year":"2001","journal-title":"Histochem Cell Biol"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib106","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1053\/plac.2001.0720","article-title":"Enzyme-cytochemically detectable glucose-6-phosphate dehydrogenase in human villous macrophages (Hofbauer cells)","volume":"22","author":"Matsubara","year":"2001","journal-title":"Placenta"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib107","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/S0891-5849(02)01005-5","article-title":"Redox signaling in vascular angiogenesis","volume":"33","author":"Maulik","year":"2002","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib108","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1172\/JCI17189","article-title":"Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia","volume":"111","author":"Maynard","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib109","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0165-0378(02)00081-5","article-title":"Pregnancy is associated with suppression of the nuclear factor kappaB\/IkappaB activation pathway in peripheral blood mononuclear cells","volume":"58","author":"McCracken","year":"2003","journal-title":"J Reprod Immunol"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib110","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/00041552-200103000-00012","article-title":"20-Hydroxyeicosatetraenoic acid and epoxyeicosatrienoic acids and blood pressure","volume":"10","author":"McGiff","year":"2001","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib111","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1067\/mob.2000.108877","article-title":"Plasma, urinary, and salivary 8-epi-prostaglandin f2alpha levels in normotensive and preeclamptic pregnancies","volume":"183","author":"McKinney","year":"2000","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib112","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.ejogrb.2003.12.030","article-title":"Pathophysiology of preeclampsia: links with implantation disorders","volume":"115","author":"Merviel","year":"2004","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib113","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/0002-9378(94)90462-6","article-title":"Preeclampsia and antioxidant nutrients: decreased plasma levels of reduced ascorbic acid, alpha-tocopherol, and beta-carotene in women with preeclampsia","volume":"17","author":"Mikhail","year":"1994","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib114","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1023\/A:1007007213846","article-title":"The effects of ascorbate and alpha-tocopherol on the NADPH-dependent lipid peroxidation in human placentalmitochondria","volume":"210","author":"Milczarek","year":"2000","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib115","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1006\/bbrc.1999.1422","article-title":"Oxidation of tetrahydrobiopterin by peroxynitrite: implications for vascular endothelial function","volume":"263","author":"Milstien","year":"1999","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib116","first-page":"261","article-title":"Vitamin E and carotene status in pre-eclamptic pregnant women from India","volume":"44","author":"Mohindra","year":"2002","journal-title":"Panminerva Med"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib117","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1093\/ajcn\/57.2.213","article-title":"Plasma ascorbic acid concentrations relate inversely to blood pressure in human subjects","volume":"57","author":"Moran","year":"1993","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib118","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1016\/j.ajog.2003.11.008","article-title":"Increased breath markers of oxidative stress in normal pregnancy and in preeclampsia","volume":"190","author":"Moretti","year":"2004","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib119","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1081\/DMR-100102340","article-title":"The isoprostanes: their quantification as an index of oxidant stress status in vivo","volume":"32","author":"Morrow","year":"2000","journal-title":"Drug Metab Rev"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib120","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1159\/000009994","article-title":"Imbalance between lipid peroxidation and antioxidant status in preeaclampsia","volume":"46","author":"Mutlu-Turkoglu","year":"1998","journal-title":"Gynecol Obstet Invest"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib121","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s00418-004-0677-x","article-title":"Oxidative stress in the placenta","volume":"122","author":"Myatt","year":"2004","journal-title":"Histochem Cell Biol"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib122","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1161\/01.HYP.28.3.488","article-title":"Nitrotyrosine residues in placenta: evidence of peroxynitrite formation and action","volume":"28","author":"Myatt","year":"1996","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib123","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0143-4004(97)80060-4","article-title":"Inducible (type II) nitric oxide synthase in human placental villous tissue of normotensive, pre-eclamptic and intrauterine growth-restricted pregnancies","volume":"18","author":"Myatt","year":"1997","journal-title":"Placenta"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib124","doi-asserted-by":"crossref","first-page":"4838","DOI":"10.1210\/en.2004-0533","article-title":"Cytotrophoblasts up-regulate soluble fms-like tyrosine kinase-1 expression under reduced oxygen: an implication for the placental vascular development and the pathophysiology of preeclampsia","volume":"145","author":"Nagamatsu","year":"2004","journal-title":"Endocrinology"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib125","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1210\/jc.85.6.2318","article-title":"Expression and relationship between endothelin-1 messenger ribonucleic acid (mRNA) and inducible\/endothelial nitric oxide synthase mRNA isoforms from normal and preeclamptic placentas","volume":"85","author":"Napolitano","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"issue":"8 Pt 1","key":"10.1016\/j.pharmthera.2005.03.001_bib126","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/S0895-7061(99)00022-9","article-title":"Alpha-tocopherol increased nitric oxide synthase activity in blood vessels of spontaneously hypertensive rats","volume":"12","author":"Newaz","year":"1999","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib127","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1161\/01.HYP.0000116220.39793.c9","article-title":"l-Arginine depletion in preeclampsia orients nitric oxide synthase toward oxidant species","volume":"43","author":"Noris","year":"2004","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib128","first-page":"81","article-title":"Hyperhomocysteinemia in preeclampsia is associated to higher risk pressure profiles","volume":"7","author":"Noto","year":"2003","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib129","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1159\/000292266","article-title":"Plasma nitric oxide levels in pregnant patients with preeclampsia and essential hypertension","volume":"41","author":"Nobunaga","year":"1996","journal-title":"Gynecol Obstet Invest"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib130","doi-asserted-by":"crossref","first-page":"3593","DOI":"10.1161\/01.CIR.96.10.3593","article-title":"Vitamins C and E inhibit O2-production in the pig coronary artery","volume":"96","author":"Nunes","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib131","doi-asserted-by":"crossref","first-page":"515","DOI":"10.3109\/00016349709024575","article-title":"Effect of nitric oxide, prostacyclin, and thromboxane on the vasospastic action of hydrogen peroxide on human umbilical artery","volume":"76","author":"Okatani","year":"1997","journal-title":"Acta Osbtet Gynecol Scand"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib132","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1046\/j.1440-1681.2003.03844.x","article-title":"Placental endothelial nitric oxide synthase localization and expression in normal human pregnancy and pre-eclampsia","volume":"30","author":"Orange","year":"2003","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib133","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S0029-7844(01)01437-5","article-title":"Placental and serum levels of carotenoids in preeclampsia","volume":"98","author":"Palan","year":"2001","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib134","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1159\/000077011","article-title":"Lipid-soluble antioxidants and pregnancy: maternal serum levels of coenzyme Q10, alpha-tocopherol and gamma-tocopherol in preeclampsia and normal pregnancy","volume":"58","author":"Palan","year":"2004","journal-title":"Gynecol Obstet Invest"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib135","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/j.1447-0756.2000.tb01343.x","article-title":"Antioxidants nutrients and lipid peroxide levels in Thai preeclamptic pregnant women","volume":"26","author":"Panburana","year":"2000","journal-title":"J Obstet Gynaecol Res"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib136","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1081\/PRG-120028285","article-title":"Evidence of increased oxidative stress, unexplained by lipid changes, is present in nulliparous black women from early gestation","volume":"23","author":"Patrick","year":"2004","journal-title":"Hypertens Pregnancy"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib137","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1210\/jc.2003-032042","article-title":"Oxidized low-density lipoproteins inhibit trophoblastic cell invasion","volume":"89","author":"Pavan","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib138","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1080\/j.1600-0412.1998.770805.x","article-title":"Increased circulating concentrations of asymmetric dimethyl arginine (ADMA), an endogenous inhibitor of nitric oxide synthesis, in preeclampsia","volume":"77","author":"Pettersson","year":"1998","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib139","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1067\/mob.2000.106676","article-title":"Pretreatment of human amnion-chorion with vitamins C and E prevents hypochlorous acid-induced damage","volume":"183","author":"Plessinger","year":"2000","journal-title":"Am J Obstet Gynecol"},{"issue":"Suppl A","key":"10.1016\/j.pharmthera.2005.03.001_bib140","doi-asserted-by":"crossref","first-page":"S72","DOI":"10.1016\/j.placenta.2004.01.003","article-title":"Trophoblast oxidative stress, antioxidants and pregnancy outcome (a review)","volume":"25","author":"Poston","year":"2004","journal-title":"Placenta"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib141","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jsgi.2003.07.007","article-title":"Renal handling of homocysteine during normal pregnancy and preeclampsia","volume":"11","author":"Powers","year":"2004","journal-title":"J Soc Gynecol Investig"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib142","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S1043-2760(01)00411-8","article-title":"The isoprostanes in biology and medicine","volume":"12","author":"Pratico","year":"2001","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib143","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1016\/S0002-9378(03)00858-5","article-title":"Effects of maternal antioxidant supplementation on maternal and fetal antioxidant levels: a randomized, double-blind study","volume":"189","author":"Pressman","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib144","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1023\/A:1026511420505","article-title":"Ontogenic profile of some antioxidants and lipid peroxidation in human placental and fetal tissues","volume":"215","author":"Qanungo","year":"2000","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib145","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1111\/j.1476-5381.1987.tb11367.x","article-title":"The anti-aggregating properties of vascular endothelium: interactions between prostacyclin and nitric oxide","volume":"92","author":"Radomski","year":"1987","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib146","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1161\/01.HYP.0000141085.98320.01","article-title":"Oxidative stress and preeclampsia: rationale for antioxidant clinical trials","volume":"44","author":"Raijmakers","year":"2004","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib147","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1471-0528.2004.00051.x","article-title":"Thiol status and antioxidant capacity in women with a history of severe pre-eclampsia","volume":"111","author":"Raijmakers","year":"2004","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib148","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1067\/mob.2001.116754","article-title":"No evidence for lipid peroxidation in severe preeclampsia","volume":"185","author":"Regan","year":"2001","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib149","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1055\/s-2007-1016248","article-title":"Endothelial dysfunction in preeclampsia","volume":"16","author":"Roberts","year":"1998","journal-title":"Semin Reprod Endocrinol"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib150","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0140-6736(00)03577-7","article-title":"Pathogenesis and genetics of pre-eclampsia","volume":"357","author":"Roberts","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib151","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/S0140-6736(99)80002-6","article-title":"Is oxidative stress the link in the two-stage model of pre-eclampsia?","volume":"354","author":"Roberts","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib152","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1177\/0091270003258190","article-title":"Homocysteine and essential hypertension","volume":"43","author":"Rodrigo","year":"2003","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib153","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0020-7292(98)00217-3","article-title":"Impaired antioxidant activity in women with pre-eclampsia","volume":"64","author":"Sagol","year":"1999","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib154","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1046\/j.1365-2796.2000.00752.x","article-title":"Antioxidant Supplementation in Atherosclerosis Prevention (ASAP) study: a randomized trial of the effect of vitamins E and C on 3-year progression of carotid atherosclerosis","volume":"248","author":"Salonen","year":"2000","journal-title":"J Intern Med"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib155","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0029-7844(96)00514-5","article-title":"Lipoprotein subfraction concentrations in preeclampsia: pathogenic parallels to atherosclerosis","volume":"89","author":"Sattar","year":"1997","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib156","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/S0140-6736(03)13177-7","article-title":"Endothelial dysfunction and raised plasma concentrations of asymmetric dimethylarginine in pregnant women who subsequently develop pre-eclampsia","volume":"361","author":"Savvidou","year":"2003","journal-title":"Lancet"},{"issue":"4 Pt 1","key":"10.1016\/j.pharmthera.2005.03.001_bib157","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/S0002-9378(96)80046-9","article-title":"Dietary consumption and plasma concentrations of vitamin E in pregnancies complicated by preeclampsia","volume":"175","author":"Schiff","year":"1996","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib158","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1067\/S0002-9378(03)00775-0","article-title":"Neurokinin B peptide serum levels are higher in normotensive pregnant women than in preeclamptic pregnant women","volume":"189","author":"Schlembach","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib159","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/S0008-6363(03)00538-8","article-title":"8-Isoprostane increases expression of interleukin-8 in human macrophages through activation of mitogen-activated protein kinases","volume":"59","author":"Scholz","year":"2003","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib160","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/S0002-9378(94)70064-8","article-title":"The role of nitric oxide in the pathogenesis of preeclampsia","volume":"171","author":"Seligman","year":"1994","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib161","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0928-4680(02)00052-4","article-title":"Placental and decidual lipid peroxidation and antioxidant defenses in preeclampsia. Lipid peroxidation in preeclampsia","volume":"9","author":"Serdar","year":"2002","journal-title":"Pathophysiology"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib162","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s00404-002-0302-y","article-title":"Lipid and protein oxidation and antioxidant function in women with mild and severe preeclampsia","volume":"268","author":"Serdar","year":"2003","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib163","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1007\/BF01645140","article-title":"Role of reactive oxygen species in biological processes","volume":"69","author":"Sies","year":"1991","journal-title":"Klin Wochenschr"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib164","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1053\/plac.2001.0629","article-title":"Placental superoxide is increased in pre-eclampsia","volume":"22","author":"Sikkema","year":"2001","journal-title":"Placenta"},{"issue":"4 Pt 1","key":"10.1016\/j.pharmthera.2005.03.001_bib165","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/S0002-9378(96)80044-5","article-title":"Evaluation of nitric oxide as a mediator of severe preeclampsia","volume":"175","author":"Silver","year":"1996","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib166","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1007\/s001250051342","article-title":"The importance of lipid-derived malondialdehyde in diabetes mellitus","volume":"43","author":"Slatter","year":"2000","journal-title":"Diabetologia"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib167","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1111\/j.1471-0528.1997.tb11528.x","article-title":"Elevated levels of serum nitrate, a stable end product of nitric oxide, in women with pre-eclampsia","volume":"104","author":"Sm\u00e1rason","year":"1997","journal-title":"Br J Obstet Gynaecol"},{"issue":"5 Pt 1","key":"10.1016\/j.pharmthera.2005.03.001_bib168","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/S0002-9378(99)70110-9","article-title":"Elevated level of free 8-iso-prostaglandin F2alpha in the decidua basalis of women with preeclampsia","volume":"181","author":"Staff","year":"1999","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib169","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1161\/01.CIR.0000085067.55901.89","article-title":"Endothelial dysfunction induced by hyperhomocyst(e)inemia: role of asymmetric dimethylarginine","volume":"108","author":"Stuhlinger","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib170","doi-asserted-by":"crossref","first-page":"12605","DOI":"10.1074\/jbc.C300012200","article-title":"Neutralization of circulating vascular endothelial growth factor (VEGF) by anti-VEGF antibodies and soluble VEGF receptor 1 (sFlt-1) induces proteinuria","volume":"278","author":"Sugimoto","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib171","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1097\/00005344-199904000-00020","article-title":"Reduced urinary excretion of nitric oxide metabolites and increased plasma levels of asymmetric dimethylarginine in men with essential hypertension","volume":"33","author":"Surdacki","year":"1999","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib173","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/S0008-6363(02)00617-X","article-title":"ADMA and oxidative stress are responsible for endothelial dysfunction in hyperhomocyst(e)inemia: effects of l-arginine and B vitamins","volume":"57","author":"Sydow","year":"2003","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib174","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1016\/S0002-9378(03)00923-2","article-title":"Fetal betamethasone treatment and neonatal outcome in preeclampsia and intrauterine growth restriction","volume":"189","author":"Szabo","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib175","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/00041552-199803000-00010","article-title":"The role of endothelium in human hypertension","volume":"7","author":"Taddei","year":"1998","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib176","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1096\/fj.00-0549fje","article-title":"Increased circulating lipid peroxides in severe preeclampsia activate NF-kappaB and upregulate ICAM-1 in vascular endothelial cells","volume":"15","author":"Takacs","year":"2001","journal-title":"FASEB J"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib177","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1067\/mob.2003.134","article-title":"Increased vascular endothelial cell production of interleukin-6 in severe preeclampsia","volume":"188","author":"Takacs","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib178","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s00428-003-0903-2","article-title":"Levels of oxidative stress and redox-related molecules in the placenta in preeclampsia and fetal growth restriction","volume":"444","author":"Takagi","year":"2004","journal-title":"Virchows Arch"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib179","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0065-2571(02)00038-9","article-title":"Importance of phase 2 gene regulation in protection against electrophile and reactive oxygen toxicity and carcinogenesis","volume":"43","author":"Talalay","year":"2003","journal-title":"Adv Enzyme Regul"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib180","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1385\/BTER:80:2:107","article-title":"Plasma extracellular superoxide dismutase activity in healthy pregnant women is not influenced by zinc supplementation","volume":"80","author":"Tamura","year":"2001","journal-title":"Biol Trace Elem Res"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib181","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s00418-004-0696-7","article-title":"Reactive oxygen species in vascular biology: implications in hypertension","volume":"122","author":"Touyz","year":"2004","journal-title":"Histochem Cell Biol"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib182","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0301-2115(03)00369-5","article-title":"Amniotic vascular endothelial growth factor (VEGF) and nitric oxide (NO) in women with subsequent preeclampsia","volume":"113","author":"Tranquilli","year":"2004","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib183","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1161\/01.ATV.15.11.2025","article-title":"Differing alpha-tocopherol oxidative lability and ascorbic acid sparing effects in buoyant and dense LDL","volume":"15","author":"Tribble","year":"1995","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib184","first-page":"445","article-title":"The correlation between plasma homocysteine and malondialdehyde levels in preeclampsia","volume":"24","author":"Tug","year":"2003","journal-title":"Neuro Endocrinol Lett"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib185","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1007\/BF00180030","article-title":"Hyperhomocysteinemia and the response to vitamin supplementation","volume":"71","author":"Ubbink","year":"1993","journal-title":"Clin Invest"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib186","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1161\/01.HYP.0000057421.28533.37","article-title":"Vitamins reverse endothelial dysfunction through regulation of eNOS and NAD(P)H oxidase activities","volume":"41","author":"\u00dclker","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib187","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0028-2243(91)90168-K","article-title":"Lipid peroxidation products, selenium-dependent glutathione peroxidase and vitamin E in normal pregnancy","volume":"42","author":"Uotila","year":"1991","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib188","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1111\/j.1471-0528.1993.tb15242.x","article-title":"Findings on lipid peroxidation and antioxidant function in hypertensive complications of pregnancy","volume":"100","author":"Uotila","year":"1993","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib189","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1161\/01.RES.0000046227.65158.F8","article-title":"Novel role of gp91(phox)-containing NAD(P)H oxidase in vascular endothelial growth factor-induced signaling and angiogenesis","volume":"91","author":"Ushio-Fukai","year":"2002","journal-title":"Circ Res"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib190","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1159\/000079067","article-title":"Hyperhomocyst(e)inemia and elevated soluble vascular cell adhesion molecule-1 concentrations are associated with an increased risk of preeclampsia","volume":"58","author":"Vadachkoria","year":"2004","journal-title":"Gynecol Obstet Invest"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib191","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s00404-002-0317-4","article-title":"Atherogenic profile in preeclampsia","volume":"268","author":"Var","year":"2003","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib192","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1159\/000074824","article-title":"Endothelial dysfunction in preeclampsia. Increased homocysteine and decreased nitric oxide levels","volume":"56","author":"Var","year":"2003","journal-title":"Gynecol Obstet Invest"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib193","series-title":"Pre-eclampsia","first-page":"189","article-title":"Eclampsia and preeclampsia: a health problem for 2000 years","author":"Villar","year":"2003"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib194","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/S0735-1097(98)00059-X","article-title":"Low plasma ascorbic acid independently predicts the presence of an unstable coronary syndrome","volume":"31","author":"Vita","year":"1998","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib195","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1034\/j.1600-079X.2001.280307.x","article-title":"Melatonin against the free radical-induced impairment of nitric oxide production in the human umbilical artery","volume":"28","author":"Waktsuki","year":"2000","journal-title":"J Pineal Res"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib196","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1172\/JCI4106","article-title":"Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor","volume":"103","author":"Wallukat","year":"1999","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib197","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1016\/0002-9378(93)90419-J","article-title":"Secretion of lipid peroxides by the human placenta","volume":"169","author":"Walsh","year":"1993","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib198","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1096\/fj.14.10.1289","article-title":"Placental isoprostane is significantly increased in preeclampsia","volume":"14","author":"Walsh","year":"2000","journal-title":"FASEB J"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib199","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1053\/plac.2000.0608","article-title":"Increased superoxide generation is associated with decreased superoxide dismutase activity and mRNA expression in placental trophoblast cells in pre-eclampsia","volume":"22","author":"Wang","year":"2001","journal-title":"Placenta"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib200","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S0143-4004(03)00132-2","article-title":"Protease chymotrypsin mediates the endothelial expression of P- and E-selectin, but not ICAM and VCAM, induced by placental trophoblasts from pre-eclamptic pregnancies","volume":"24","author":"Wang","year":"2003","journal-title":"Placenta"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib201","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.ajog.2003.09.049","article-title":"Evidence of endothelial dysfunction in preeclampsia: decreased endothelial nitric oxide synthase expression is associated with increased cell permeability in endothelial cells from preeclampsia","volume":"190","author":"Wang","year":"2004","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib202","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0143-4004(97)80064-1","article-title":"Variations in expression of copper\/zinc superoxide dismutase in villous trophoblast of the human placenta with gestational age","volume":"18","author":"Watson","year":"1997","journal-title":"Placenta"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib203","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1210\/jc.83.5.1697","article-title":"Susceptibility of human placental syncytiotrophoblastic mitochondria to oxygen-mediated damage in relation to gestational age","volume":"83","author":"Watson","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib204","first-page":"74","article-title":"Oxidative DNA damage in placentas from normal and pre-eclamptic pregnancies","volume":"445","author":"Wiktor","year":"2004","journal-title":"Virchows Arch"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib205","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S0895-7061(03)00897-5","article-title":"Plasma carotenoids, retinol, tocopherols, and lipoproteins in preeclamptic and normotensive pregnant Zimbabwean women","volume":"16","author":"Williams","year":"2003","journal-title":"Am J Hypertens"},{"issue":"6 Pt 1","key":"10.1016\/j.pharmthera.2005.03.001_bib206","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1016\/0002-9378(91)90018-M","article-title":"Antioxidant systems in normal pregnancy and in pregnancy-induced hypertension","volume":"165","author":"Wisdom","year":"1991","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib207","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1067\/mob.2001.115868","article-title":"Vitamins C and E: missing links in preventing preterm premature rupture of membranes?","volume":"185","author":"Woods","year":"2001","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib208","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1046\/j.1523-1755.1999.00596.x","article-title":"Free-radical-generated F2-isoprostane stimulates cell proliferation and endothelin-1 expression on endothelial cells","volume":"56","author":"Yura","year":"1999","journal-title":"Kidney Int"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib209","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/tera.1045","article-title":"Vitamins C and E improve rat embryonic antioxidant defense mechanism in diabetic culture medium","volume":"64","author":"Zaken","year":"2001","journal-title":"Teratology"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib210","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ijgo.2003.08.001","article-title":"Placental and cord malondialdehyde and maternal and perinatal outcomes","volume":"85","author":"Zetero\u011flu","year":"2004","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib211","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1523-1755.2004.00372.x","article-title":"Up-regulation of kidney NAD(P)H oxidase and calcineurin in SHR: reversal by lifelong antioxidant supplementation","volume":"65","author":"Zhan","year":"2004","journal-title":"Kidney Int"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib212","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1093\/aje\/153.6.572","article-title":"Plasma concentrations of carotenoids, retinol, and tocopherols in preeclamptic and normotensive pregnant women","volume":"153","author":"Zhang","year":"2001","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib213","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1097\/00001648-200207000-00008","article-title":"Vitamin C and the risk of preeclampsia\u2014results from dietary questionnaire and plasma assay","volume":"13","author":"Zhang","year":"2002","journal-title":"Epidemiology"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib214","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/S0002-9440(10)65390-4","article-title":"Selective nitration of prostacyclin synthase and defective vasorelaxation in atherosclerosic bovine coronary arteries","volume":"54","author":"Zou","year":"1999","journal-title":"Am J Pathol"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib215","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1053\/plac.2000.0606","article-title":"Protein carbonyls in decidua and placenta of pre-eclamptic women as markers for oxidative stress","volume":"22","author":"Zusterzeel","year":"2001","journal-title":"Placenta"},{"key":"10.1016\/j.pharmthera.2005.03.001_bib216","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1081\/PRG-120002908","article-title":"Ethene and other biomarkers of oxidative stress in hypertensive disorders of pregnancy","volume":"21","author":"Zusterzeel","year":"2002","journal-title":"Hypertens Pregnancy"}],"container-title":["Pharmacology & Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725805000586?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725805000586?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,7]],"date-time":"2020-04-07T10:43:54Z","timestamp":1586256234000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163725805000586"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,8]]},"references-count":215,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,8]]}},"alternative-id":["S0163725805000586"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmthera.2005.03.001","relation":{},"ISSN":["0163-7258"],"issn-type":[{"value":"0163-7258","type":"print"}],"subject":[],"published":{"date-parts":[[2005,8]]}}}